Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
39
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Lemaitre Dan | Director | 22 | $99.8K | $2.8K | 2020-09-04 |
| Pinto Cynthia Buch | Interim CFO | 5 | $0 | $1.1K | 2020-08-12 |
| Brady Timothy Nicholas | Controller and Corp Secretary | 2 | $0 | $140 | 2020-08-12 |
| Thompson Matthew | Chief Medical Officer | 20 | $0 | $2.0K | 2020-08-12 |
| Wilder Thomas | Director | 28 | $0 | $713.3K | 2020-08-12 |
| Onopchenko John | Chief Operating Officer | 23 | $200.0K | $53.1K | 2020-08-12 |
| WALLER GREGORY D | Director | 34 | $0 | $1.79M | 2020-08-12 |
| Fecho Jeff | Chief Quality Officer | 10 | $0 | $0 | 2020-08-05 |
| Mahboob Vaseem | VP, Quality | 34 | $297.9K | $0 | 2020-03-24 |
| Kiernan Jane E | Director | 1 | $0 | $0 | 2020-03-18 |
| Zehren John | Chief Commercial Officer | 4 | $0 | $0 | 2020-01-08 |
| HAYDEN JEREMY B. | General Counsel | 8 | $0 | $0 | 2019-10-03 |
| Norwalk Leslie V | Director | 6 | $0 | $0 | 2019-08-05 |
| Zenty III Thomas F | Director | 12 | $85.4K | $0 | 2019-08-05 |
| NEELS GUIDO J | Director | 12 | $551.0K | $0 | 2019-04-03 |
| McDermott John D | Director | 80 | $637.2K | $2.95M | 2018-05-29 |
| Chavez Christopher G. | Director | 10 | $0 | $91 | 2018-05-29 |
| Nagel Laura | VP, Quality | 1 | $0 | $0 | 2018-03-13 |
| Mitchell Robert D | President, International | 47 | $9.5K | $1.30M | 2017-06-19 |
| O'Quinn Shari L | VP, Clinical & Regulatory | 7 | $0 | $0 | 2017-05-31 |
| Lima Jose A. | VP-Quality | 23 | $0 | $122.6K | 2016-08-19 |
| Chobotov Michael V. | Chief Technology Officer | 5 | $0 | $173.6K | 2016-08-05 |
| DeJohn Joseph A. | Vice President - Sales | 20 | $0 | $12.0K | 2016-07-08 |
| DePalma Amanda L. | VP, Global Marketing | 7 | $0 | $8.6K | 2016-06-01 |
| Machek James Edward | VP-Research & Development | 26 | $0 | $110.7K | 2016-06-01 |
| Jennings David M. | VP-Human Resources | 14 | $0 | $12.0K | 2016-06-01 |
| Ferracci Cecile | General Manager, Europe | 2 | $0 | $0 | 2016-02-04 |
| Love Charles Steele | VP-Clinical Affairs | 18 | $23.4K | $172.6K | 2016-01-26 |
| Abraham Todd | VP of Operations | 21 | $39.7K | $158.9K | 2015-11-13 |
| Thunen Shelley B | Other | 12 | $0 | $0 | 2015-10-19 |
| Fauls Janet Mary | Vice President RA/QA/QC | 25 | $0 | $1.58M | 2015-05-28 |
| Lyons Ruth Anne | VP Global Marketing | 4 | $0 | $0 | 2014-03-14 |
| SCHRECK STEFAN | Vice President | 18 | $0 | $3.35M | 2013-10-11 |
| Greenstein Leonard M. | VP Finance & Corp Controller | 8 | $0 | $17.6K | 2013-10-03 |
| Sorsher Gary I. | Vice President - Quality | 13 | $0 | $363.2K | 2013-09-27 |
| Tyler Martin | VP, International | 17 | $0 | $733.6K | 2013-03-15 |
| DE GREEF RODERICK | Director | 42 | $0 | $1.18M | 2013-03-08 |
| Krist Robert John | Chief Financial Officer | 62 | $0 | $5.54M | 2012-12-28 |
| ESSEX WOODLANDS HEALTH VENTURES FUND VII LP | 10% Owner | 6 | $0 | $56.83M | 2012-11-01 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Lemaitre Dan | Director | S Sale | 2020-09-04 | 2020-09-17 | 33,709 | $0.05 | $1.7K | 15,553 | SEC↗ |
| Lemaitre Dan | Director | S Sale | 2020-09-04 | 2020-09-17 | 15,553 | $0.05 | $778 | 0 | SEC↗ |
| Lemaitre Dan | Director | S Sale | 2020-09-04 | 2020-09-17 | 2,582 | $0.05 | $129 | 49,262 | SEC↗ |
| Lemaitre Dan | Director | S Sale | 2020-08-14 | 2020-08-19 | 1,127 | $0.08 | $90 | 51,844 | SEC↗ |
| Lemaitre Dan | Director | S Sale | 2020-08-13 | 2020-08-19 | 1,126 | $0.09 | $101 | 52,971 | SEC↗ |
| Pinto Cynthia Buch | Interim CFO | S Sale | 2020-08-12 | 2020-08-14 | 12,003 | $0.09 | $1.1K | 6,304 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | S Sale | 2020-08-12 | 2020-08-14 | 21,888 | $0.09 | $2.0K | 52,878 | SEC↗ |
| Wilder Thomas | Director | S Sale | 2020-08-12 | 2020-08-14 | 12,088 | $0.08 | $967 | 0 | SEC↗ |
| Wilder Thomas | Director | S Sale | 2020-08-12 | 2020-08-14 | 15,776 | $0.08 | $1.3K | 12,088 | SEC↗ |
| Brady Timothy Nicholas | Controller and Corp Secretar | S Sale | 2020-08-12 | 2020-08-14 | 1,628 | $0.08 | $130 | 1,004 | SEC↗ |
| Brady Timothy Nicholas | Controller and Corp Secretar | S Sale | 2020-08-12 | 2020-08-14 | 113 | $0.09 | $10 | 891 | SEC↗ |
| Onopchenko John | CEO and Director | S Sale | 2020-08-12 | 2020-08-14 | 57,415 | $0.88 | $50.5K | 197,261 | SEC↗ |
| Onopchenko John | CEO and Director | S Sale | 2020-08-12 | 2020-08-14 | 1,306 | $0.09 | $118 | 195,955 | SEC↗ |
| Onopchenko John | CEO and Director | S Sale | 2020-08-12 | 2020-08-14 | 30,257 | $0.08 | $2.4K | 165,698 | SEC↗ |
| WALLER GREGORY D | Director | S Sale | 2020-08-12 | 2020-08-14 | 28,630 | $0.08 | $2.3K | 710 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | D To issuer | 2020-08-05 | 2020-08-07 | 3,417 | $0.07 | $239 | 74,766 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | D To issuer | 2020-08-05 | 2020-08-07 | 30,433 | — | $0 | 78,183 | SEC↗ |
| Onopchenko John | CEO and Director | A Award | 2020-08-05 | 2020-08-07 | 9,424 | $0.07 | $660 | 254,176 | SEC↗ |
| Onopchenko John | CEO and Director | A Award | 2020-08-05 | 2020-08-07 | 167,870 | — | $0 | 263,600 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | A Award | 2020-08-05 | 2020-08-07 | 20,700 | — | $0 | 25,678 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | D To issuer | 2020-08-05 | 2020-08-07 | 1,946 | $0.07 | $136 | 23,732 | SEC↗ |
| Pinto Cynthia Buch | Interim CFO | A Award | 2020-08-05 | 2020-08-07 | 891 | $0.07 | $62 | 23,658 | SEC↗ |
| Pinto Cynthia Buch | Interim CFO | A Award | 2020-08-05 | 2020-08-07 | 24,410 | — | $0 | 24,549 | SEC↗ |
| Pinto Cynthia Buch | Interim CFO | A Award | 2020-08-05 | 2020-08-14 | 24,410 | — | $0 | 19,198 | SEC↗ |
| Pinto Cynthia Buch | Interim CFO | A Award | 2020-08-05 | 2020-08-14 | 891 | $0.07 | $62 | 18,307 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | F Tax w/h | 2020-06-25 | 2020-06-26 | 693 | $0.85 | $589 | 25,678 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | A Award | 2020-06-25 | 2020-06-26 | 6,172 | — | $0 | 26,371 | SEC↗ |
| Onopchenko John | CEO and Director | A Award | 2020-05-02 | 2020-05-05 | 60,443 | — | $0 | 270,568 | SEC↗ |
| Onopchenko John | CEO and Director | F Tax w/h | 2020-05-02 | 2020-05-05 | 6,968 | $0.89 | $6.2K | 263,600 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2020-03-24 | 2020-03-26 | 47,010 | — | $0 | 115,341 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | F Tax w/h | 2020-03-24 | 2020-03-26 | 3,625 | $0.94 | $3.4K | 111,716 | SEC↗ |
| Kiernan Jane E | Director | A Award | 2020-03-18 | 2020-03-18 | 103,847 | — | $0 | 103,847 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award | 2020-01-31 | 2020-02-04 | 1,914 | — | $0 | 78,966 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | F Tax w/h | 2020-01-31 | 2020-02-04 | 783 | $1.00 | $783 | 78,183 | SEC↗ |
| Zehren John | Chief Commercial Officer | F Tax w/h | 2020-01-08 | 2020-01-09 | 2,726 | $1.98 | $5.4K | 40,138 | SEC↗ |
| Zehren John | Chief Commercial Officer | A Award | 2020-01-07 | 2020-01-09 | 20,000 | — | $0 | 42,864 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | F Tax w/h | 2019-12-30 | 2020-01-02 | 3,393 | $1.68 | $5.7K | 115,341 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2019-12-30 | 2020-01-02 | 47,010 | — | $0 | 118,734 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | F Tax w/h | 2019-12-30 | 2020-01-02 | 5,278 | $1.68 | $8.9K | 78,966 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award | 2019-12-30 | 2020-01-02 | 47,011 | — | $0 | 84,244 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2019-12-13 | 2019-12-17 | 47,010 | — | $0 | 121,719 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | F Tax w/h | 2019-12-13 | 2019-12-17 | 2,986 | $2.55 | $7.6K | 118,733 | SEC↗ |
| WALLER GREGORY D | Director | S Sale | 2019-11-11 | 2019-11-13 | 582 | $3.00 | $1.7K | 29,340 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | A Award | 2019-10-03 | 2019-10-07 | 12,500 | — | $0 | 36,250 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | F Tax w/h | 2019-10-03 | 2019-10-07 | 4,210 | $3.53 | $14.9K | 32,040 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | D To issuer deriv | 2019-09-30 | 2019-10-01 | 23,601 | — | $0 | 0 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | A Award deriv | 2019-09-30 | 2019-10-01 | 7,868 | — | $0 | 7,868 | SEC↗ |
| Lemaitre Dan | Director | D To issuer deriv | 2019-09-30 | 2019-10-01 | 2,000 | — | $0 | 0 | SEC↗ |
| Lemaitre Dan | Director | D To issuer deriv | 2019-09-30 | 2019-10-01 | 2,000 | — | $0 | 0 | SEC↗ |
| Lemaitre Dan | Director | D To issuer deriv | 2019-09-30 | 2019-10-01 | 5,000 | — | $0 | 0 | SEC↗ |
| Lemaitre Dan | Director | A Award deriv | 2019-09-30 | 2019-10-01 | 2,834 | — | $0 | 2,834 | SEC↗ |
| Wilder Thomas | Director | A Award deriv | 2019-09-27 | 2019-10-01 | 417 | — | $0 | 417 | SEC↗ |
| Wilder Thomas | Director | D To issuer deriv | 2019-09-27 | 2019-10-01 | 1,250 | — | $0 | 0 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | D To issuer deriv | 2019-09-27 | 2019-10-01 | 9,907 | — | $0 | 0 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | D To issuer deriv | 2019-09-27 | 2019-10-01 | 8,999 | — | $0 | 0 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award deriv | 2019-09-27 | 2019-10-01 | 6,304 | — | $0 | 6,304 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award deriv | 2019-09-27 | 2019-10-01 | 10,959 | — | $0 | 10,959 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | D To issuer deriv | 2019-09-27 | 2019-10-01 | 10,999 | — | $0 | 0 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | D To issuer deriv | 2019-09-27 | 2019-10-01 | 11,594 | — | $0 | 0 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | D To issuer deriv | 2019-09-27 | 2019-10-01 | 13,702 | — | $0 | 0 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | A Award deriv | 2019-09-27 | 2019-10-01 | 2,263 | — | $0 | 2,263 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | D To issuer deriv | 2019-09-27 | 2019-10-01 | 6,789 | — | $0 | 0 | SEC↗ |
| Onopchenko John | CEO and Director | D To issuer deriv | 2019-09-27 | 2019-10-01 | 19,034 | — | $0 | 0 | SEC↗ |
| Onopchenko John | CEO and Director | A Award deriv | 2019-09-27 | 2019-10-01 | 12,968 | — | $0 | 12,968 | SEC↗ |
| Onopchenko John | CEO and Director | D To issuer deriv | 2019-09-27 | 2019-10-01 | 19,864 | — | $0 | 0 | SEC↗ |
| Wilder Thomas | Director | S Sale | 2019-08-14 | 2019-08-15 | 1,369 | $6.61 | $9.0K | 27,864 | SEC↗ |
| WALLER GREGORY D | Director | S Sale | 2019-08-14 | 2019-08-15 | 715 | $6.61 | $4.7K | 29,922 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award deriv | 2019-08-05 | 2019-08-06 | 60,867 | $6.67 | $406.0K | 60,867 | SEC↗ |
| WALLER GREGORY D | Director | A Award deriv | 2019-08-05 | 2019-08-06 | 9,023 | $6.67 | $60.2K | 9,023 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award deriv | 2019-08-05 | 2019-08-06 | 64,800 | $6.67 | $432.2K | 64,800 | SEC↗ |
| Wilder Thomas | Director | A Award deriv | 2019-08-05 | 2019-08-06 | 9,023 | $6.67 | $60.2K | 9,023 | SEC↗ |
| Norwalk Leslie V | Director | A Award deriv | 2019-08-05 | 2019-08-06 | 9,023 | $6.67 | $60.2K | 9,023 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | A Award deriv | 2019-08-05 | 2019-08-06 | 41,400 | $6.67 | $276.1K | 41,400 | SEC↗ |
| Zehren John | Chief Commercial Officer | A Award deriv | 2019-08-05 | 2019-08-06 | 30,600 | $6.67 | $204.1K | 30,600 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | A Award deriv | 2019-08-05 | 2019-08-06 | 38,000 | $6.67 | $253.5K | 38,000 | SEC↗ |
| Lemaitre Dan | Director | A Award deriv | 2019-08-05 | 2019-08-06 | 21,913 | $6.67 | $146.2K | 21,913 | SEC↗ |
| Onopchenko John | CEO and Director | A Award deriv | 2019-08-05 | 2019-08-06 | 497,041 | — | $0 | 497,041 | SEC↗ |
| Zenty III Thomas F | Director | A Award deriv | 2019-08-05 | 2019-08-06 | 9,023 | $6.67 | $60.2K | 9,023 | SEC↗ |
| Lemaitre Dan | Director | A Award deriv | 2019-08-05 | 2019-09-12 | 9,023 | $6.67 | $60.2K | 9,023 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award | 2019-08-05 | 2019-08-06 | 30,433 | — | $0 | 84,244 | SEC↗ |
| WALLER GREGORY D | Director | A Award | 2019-08-05 | 2019-08-06 | 13,494 | — | $0 | 30,637 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2019-08-05 | 2019-08-06 | 32,400 | — | $0 | 121,720 | SEC↗ |
| Wilder Thomas | Director | A Award | 2019-08-05 | 2019-08-06 | 13,494 | — | $0 | 29,233 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2019-08-05 | 2019-08-06 | 13,494 | — | $0 | 29,932 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | A Award | 2019-08-05 | 2019-08-06 | 20,700 | — | $0 | 26,371 | SEC↗ |
| Zehren John | Chief Commercial Officer | A Award | 2019-08-05 | 2019-08-06 | 15,300 | — | $0 | 42,864 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | A Award | 2019-08-05 | 2019-08-06 | 19,000 | — | $0 | 36,250 | SEC↗ |
| Lemaitre Dan | Director | A Award | 2019-08-05 | 2019-08-06 | 13,494 | — | $0 | 46,601 | SEC↗ |
| Onopchenko John | CEO and Director | A Award | 2019-08-05 | 2019-08-06 | 167,870 | — | $0 | 270,068 | SEC↗ |
| Zenty III Thomas F | Director | A Award | 2019-08-05 | 2019-08-06 | 13,494 | — | $0 | 35,547 | SEC↗ |
| Lemaitre Dan | Director | A Award | 2019-08-05 | 2019-09-12 | 20,990 | — | $0 | 54,097 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | A Award | 2019-06-25 | 2019-06-27 | 6,172 | — | $0 | 6,383 | SEC↗ |
| Fecho Jeff | Chief Quality Officer | F Tax w/h | 2019-06-25 | 2019-06-27 | 712 | $7.87 | $5.6K | 5,671 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | F Tax w/h | 2019-05-08 | 2019-05-10 | 421 | $6.40 | $2.7K | 53,811 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award | 2019-05-08 | 2019-05-10 | 1,250 | — | $0 | 54,232 | SEC↗ |
| Wilder Thomas | Director | S Sale | 2019-05-07 | 2019-05-09 | 1,455 | $6.34 | $9.2K | 15,739 | SEC↗ |
| Onopchenko John | CEO and Director | A Award | 2019-05-02 | 2019-05-03 | 60,443 | — | $0 | 108,860 | SEC↗ |
| Onopchenko John | CEO and Director | F Tax w/h | 2019-05-02 | 2019-05-03 | 6,968 | $6.32 | $44.0K | 101,892 | SEC↗ |
| NEELS GUIDO J | Director | P Buy | 2019-04-03 | 2019-04-03 | 22,692 | $6.61 | $150.0K | 43,200 | SEC↗ |
| Zenty III Thomas F | Director | P Buy | 2019-04-03 | 2019-04-03 | 3,025 | $6.61 | $20.0K | 22,053 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | A Award | 2019-04-03 | 2019-04-03 | 12,500 | — | $0 | 17,250 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | P Buy | 2019-04-03 | 2019-04-03 | 15,128 | $6.61 | $100.0K | 76,820 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2019-04-03 | 2019-04-03 | 12,500 | — | $0 | 89,320 | SEC↗ |
| Onopchenko John | CEO and Director | P Buy | 2019-04-03 | 2019-04-03 | 30,257 | $6.61 | $200.0K | 96,360 | SEC↗ |
| Onopchenko John | CEO and Director | A Award | 2019-04-03 | 2019-04-03 | 12,500 | — | $0 | 108,860 | SEC↗ |
| Onopchenko John | CEO and Director | A Award deriv | 2019-02-13 | 2019-02-20 | 400,000 | $0.58 | $232.0K | 400,000 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award | 2019-01-31 | 2019-02-01 | 19,142 | — | $0 | 542,319 | SEC↗ |
| HAYDEN JEREMY B. | General Counsel | A Award deriv | 2018-12-30 | 2019-01-02 | 216,449 | $0.74 | $160.2K | 216,449 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award deriv | 2018-12-30 | 2019-01-02 | 225,621 | $0.74 | $167.0K | 225,621 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award deriv | 2018-12-30 | 2019-01-02 | 225,621 | $0.74 | $167.0K | 225,621 | SEC↗ |
| Zenty III Thomas F | Director | A Award | 2018-12-30 | 2019-01-02 | 120,887 | — | $0 | 190,283 | SEC↗ |
| Wilder Thomas | Director | A Award | 2018-12-30 | 2019-01-02 | 120,887 | — | $0 | 171,947 | SEC↗ |
| Lemaitre Dan | Director | A Award | 2018-12-30 | 2019-01-02 | 181,330 | — | $0 | 331,065 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2018-12-30 | 2019-01-02 | 120,887 | — | $0 | 164,378 | SEC↗ |
| Onopchenko John | CEO and Director | A Award | 2018-12-30 | 2019-01-02 | 604,433 | — | $0 | 661,037 | SEC↗ |
| WALLER GREGORY D | Director | A Award | 2018-12-30 | 2019-01-02 | 120,887 | — | $0 | 171,437 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2018-12-30 | 2019-01-02 | 470,115 | — | $0 | 616,927 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | D To issuer | 2018-12-30 | 2019-01-02 | 15,000 | — | $0 | 53,062 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award | 2018-12-30 | 2019-01-02 | 470,115 | — | $0 | 523,177 | SEC↗ |
| NEELS GUIDO J | Director | A Award | 2018-12-30 | 2019-01-03 | 120,887 | — | $0 | 205,089 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | P Buy | 2018-08-16 | 2018-08-20 | 30,000 | $2.43 | $72.9K | 146,812 | SEC↗ |
| McDermott John D | Director | F Tax w/h | 2018-05-29 | 2018-05-30 | 7,286 | $5.65 | $41.2K | 879,423 | SEC↗ |
| Chavez Christopher G. | Director | S Sale | 2018-05-29 | 2018-05-30 | 8 | $5.64 | $45 | 378,354 | SEC↗ |
| Chavez Christopher G. | Director | S Sale | 2018-05-29 | 2018-05-30 | 8 | $5.70 | $46 | 378,346 | SEC↗ |
| McDermott John D | Director | A Award | 2018-05-28 | 2018-05-30 | 48,222 | — | $0 | 886,709 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | A Award | 2018-05-15 | 2018-06-01 | 31,000 | — | $0 | 79,411 | SEC↗ |
| Thompson Matthew | Chief Medical Officer | F Tax w/h | 2018-05-15 | 2018-06-01 | 10,719 | $4.87 | $52.2K | 68,692 | SEC↗ |
| McDermott John D | Director | M Exercise deriv | 2018-05-10 | 2018-05-14 | 177,065 | — | $0 | 0 | SEC↗ |
| McDermott John D | Director | F Tax w/h | 2018-05-10 | 2018-05-14 | 133,503 | $4.73 | $631.5K | 886,709 | SEC↗ |
| McDermott John D | Director | M Exercise | 2018-05-10 | 2018-05-14 | 177,065 | $2.67 | $472.8K | 1,020,212 | SEC↗ |
| Lemaitre Dan | Director | A Award | 2018-05-09 | 2018-05-11 | 46,814 | — | $0 | 149,735 | SEC↗ |
| Onopchenko John | Chief Executive Officer | A Award deriv | 2018-05-02 | 2018-05-04 | 198,650 | $4.36 | $866.1K | 198,650 | SEC↗ |
| McDermott John D | Chief Executive Officer | M Exercise deriv | 2018-03-27 | 2018-03-28 | 250,000 | — | $0 | 155,381 | SEC↗ |
| McDermott John D | Chief Executive Officer | M Exercise | 2018-03-27 | 2018-03-28 | 250,000 | $2.67 | $667.5K | 838,659 | SEC↗ |
| Nagel Laura | VP, Quality | D To issuer | 2018-03-13 | 2018-03-15 | 5,000 | — | $0 | 48,860 | SEC↗ |
| Mahboob Vaseem | VP, Quality | D To issuer | 2018-03-13 | 2018-03-15 | 28,000 | — | $0 | 116,812 | SEC↗ |
| McDermott John D | Chief Executive Officer | D To issuer | 2018-03-13 | 2018-03-15 | 140,000 | — | $0 | 588,659 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | F Tax w/h | 2018-02-07 | 2018-02-09 | 4,632 | $4.05 | $18.8K | 144,812 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2018-02-07 | 2018-02-09 | 33,201 | — | $0 | 149,444 | SEC↗ |
| McDermott John D | Chief Executive Officer | F Tax w/h | 2018-02-07 | 2018-02-09 | 14,467 | $4.05 | $58.6K | 728,659 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2018-02-07 | 2018-02-09 | 106,242 | — | $0 | 743,126 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2017-11-08 | 2017-11-08 | 25,000 | — | $0 | 149,444 | SEC↗ |
| Onopchenko John | Chief Operating Officer | A Award deriv | 2017-10-30 | 2018-03-01 | 190,353 | $5.30 | $1.01M | 190,353 | SEC↗ |
| Onopchenko John | Chief Operating Officer | A Award | 2017-10-30 | 2018-03-01 | 56,604 | — | $0 | 56,604 | SEC↗ |
| Onopchenko John | Chief Operating Officer | A Award deriv | 2017-10-30 | 2017-11-01 | 187,484 | $5.30 | $993.7K | 187,484 | SEC↗ |
| Onopchenko John | Chief Operating Officer | A Award | 2017-10-30 | 2017-11-01 | 56,604 | — | $0 | 56,604 | SEC↗ |
| McDermott John D | Chief Executive Officer | D To issuer | 2017-06-19 | 2017-06-20 | 48,222 | — | $0 | 743,126 | SEC↗ |
| Mitchell Robert D | President | D To issuer | 2017-06-19 | 2017-06-20 | 18,083 | — | $0 | 316,886 | SEC↗ |
| McDermott John D | Chief Executive Officer | F Tax w/h | 2017-06-01 | 2017-06-02 | 5,821 | $4.79 | $27.9K | 791,348 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2017-06-01 | 2017-06-02 | 48,222 | — | $0 | 797,169 | SEC↗ |
| Mitchell Robert D | President | F Tax w/h | 2017-06-01 | 2017-06-02 | 2,183 | $4.79 | $10.5K | 334,969 | SEC↗ |
| Mitchell Robert D | President | A Award | 2017-06-01 | 2017-06-02 | 18,083 | — | $0 | 337,152 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award deriv | 2017-05-31 | 2017-06-02 | 110,000 | $4.82 | $530.2K | 110,000 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award deriv | 2017-05-31 | 2017-06-02 | 270,000 | $4.82 | $1.30M | 270,000 | SEC↗ |
| Mitchell Robert D | President | A Award deriv | 2017-05-31 | 2017-06-02 | 90,000 | $4.82 | $433.8K | 90,000 | SEC↗ |
| O'Quinn Shari L | VP, Clinical & Regulatory | A Award deriv | 2017-05-31 | 2017-06-06 | 65,000 | $4.82 | $313.3K | 65,000 | SEC↗ |
| NEELS GUIDO J | Director | A Award | 2017-05-31 | 2017-06-02 | 22,822 | — | $0 | 84,202 | SEC↗ |
| WALLER GREGORY D | Director | A Award | 2017-05-31 | 2017-06-02 | 22,822 | — | $0 | 50,550 | SEC↗ |
| Chavez Christopher G. | Director | A Award | 2017-05-31 | 2017-06-02 | 22,822 | — | $0 | 378,362 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2017-05-31 | 2017-06-02 | 22,822 | — | $0 | 43,491 | SEC↗ |
| Wilder Thomas | Director | A Award | 2017-05-31 | 2017-06-02 | 22,822 | — | $0 | 51,060 | SEC↗ |
| Zenty III Thomas F | Director | A Award | 2017-05-31 | 2017-06-02 | 22,822 | — | $0 | 69,396 | SEC↗ |
| Lemaitre Dan | Director | A Award | 2017-05-31 | 2017-06-02 | 34,232 | — | $0 | 102,921 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2017-05-31 | 2017-06-02 | 28,000 | — | $0 | 121,186 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2017-05-31 | 2017-06-02 | 140,000 | — | $0 | 797,169 | SEC↗ |
| Mitchell Robert D | President | A Award | 2017-05-31 | 2017-06-02 | 23,000 | — | $0 | 337,152 | SEC↗ |
| O'Quinn Shari L | VP, Clinical & Regulatory | A Award | 2017-05-31 | 2017-06-06 | 18,000 | — | $0 | 94,356 | SEC↗ |
| Mitchell Robert D | President | F Tax w/h | 2017-05-25 | 2017-06-02 | 1,547 | $4.99 | $7.7K | 314,152 | SEC↗ |
| Mitchell Robert D | President | A Award | 2017-05-25 | 2017-06-02 | 13,288 | — | $0 | 315,699 | SEC↗ |
| Lemaitre Dan | Director | P Buy | 2017-05-22 | 2017-05-23 | 22,522 | $4.43 | $99.8K | 68,689 | SEC↗ |
| Zenty III Thomas F | Director | P Buy | 2017-05-22 | 2017-05-24 | 5,000 | $4.44 | $22.2K | 46,574 | SEC↗ |
| Mitchell Robert D | President | P Buy | 2017-05-19 | 2017-05-22 | 2,200 | $4.32 | $9.5K | 315,699 | SEC↗ |
| NEELS GUIDO J | Director | P Buy | 2017-05-19 | 2017-05-23 | 20,000 | $4.32 | $86.4K | 61,380 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2017-05-19 | 2017-05-30 | 25,000 | $4.45 | $111.3K | 657,169 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2017-04-06 | 2017-04-07 | 55,310 | — | $0 | 98,370 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | F Tax w/h | 2017-04-06 | 2017-04-07 | 5,184 | $6.75 | $35.0K | 93,186 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2017-02-27 | 2017-02-28 | 55,310 | — | $0 | 103,592 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | F Tax w/h | 2017-02-27 | 2017-02-28 | 5,222 | $6.41 | $33.5K | 98,370 | SEC↗ |
| Mitchell Robert D | President | A Award | 2017-02-09 | 2017-02-13 | 33,201 | — | $0 | 315,939 | SEC↗ |
| Mitchell Robert D | President | F Tax w/h | 2017-02-09 | 2017-02-13 | 4,965 | $6.95 | $34.5K | 310,974 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | F Tax w/h | 2017-02-07 | 2017-02-09 | 4,919 | $6.94 | $34.1K | 103,592 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2017-02-07 | 2017-02-09 | 33,201 | — | $0 | 108,511 | SEC↗ |
| McDermott John D | Chief Executive Officer | F Tax w/h | 2017-02-07 | 2017-02-09 | 17,276 | $6.94 | $119.9K | 629,644 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2017-02-07 | 2017-02-09 | 106,242 | — | $0 | 646,920 | SEC↗ |
| McDermott John D | Chief Executive Officer | F Tax w/h | 2017-01-09 | 2017-01-10 | 20,588 | $5.71 | $117.6K | 646,920 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2017-01-09 | 2017-01-10 | 108,538 | — | $0 | 667,508 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2016-12-14 | 2016-12-15 | 1,600 | $6.64 | $10.6K | 659,208 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2016-12-14 | 2016-12-15 | 400 | $6.66 | $2.7K | 662,108 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2016-12-14 | 2016-12-15 | 2,500 | $6.65 | $16.6K | 661,708 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2016-12-14 | 2016-12-15 | 1,800 | $6.67 | $12.0K | 663,908 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2016-12-14 | 2016-12-15 | 100 | $6.63 | $663 | 657,608 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2016-12-14 | 2016-12-15 | 1,000 | $6.76 | $6.8K | 667,508 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2016-12-14 | 2016-12-15 | 2,600 | $6.68 | $17.4K | 666,508 | SEC↗ |
| Zenty III Thomas F | Director | P Buy | 2016-12-14 | 2016-12-15 | 3,000 | $6.51 | $19.5K | 41,574 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | P Buy | 2016-12-13 | 2016-12-15 | 20,000 | $6.25 | $125.0K | 108,511 | SEC↗ |
| O'Quinn Shari L | VP, Clinical & Regulatory | A Award | 2016-12-09 | 2016-12-13 | 21,834 | — | $0 | 76,356 | SEC↗ |
| NEELS GUIDO J | Director | P Buy | 2016-11-18 | 2016-11-22 | 13,000 | $7.69 | $100.0K | 41,380 | SEC↗ |
| Zenty III Thomas F | Director | P Buy | 2016-11-18 | 2016-11-22 | 3,000 | $7.89 | $23.7K | 38,574 | SEC↗ |
| Lima Jose A. | VP-Quality | M Exercise deriv | 2016-08-19 | 2016-08-22 | 4,710 | — | $0 | 32,971 | SEC↗ |
| Lima Jose A. | VP-Quality | M Exercise | 2016-08-19 | 2016-08-22 | 4,710 | $7.53 | $35.5K | 42,594 | SEC↗ |
| Lima Jose A. | VP-Quality | S Sale | 2016-08-19 | 2016-08-22 | 4,710 | $11.68 | $55.0K | 37,884 | SEC↗ |
| Chobotov Michael V. | Chief Technology Officer | S Sale | 2016-08-05 | 2016-08-08 | 14,000 | $12.40 | $173.6K | 189,269 | SEC↗ |
| DeJohn Joseph A. | General Manager, Asia & Pac | F Tax w/h | 2016-07-08 | 2016-07-11 | 4,376 | $13.76 | $60.2K | 153,471 | SEC↗ |
| DeJohn Joseph A. | General Manager, Asia & Pac | A Award | 2016-07-08 | 2016-07-11 | 28,944 | — | $0 | 157,847 | SEC↗ |
| WALLER GREGORY D | Director | S Sale | 2016-06-03 | 2016-06-06 | 7,800 | $12.86 | $100.3K | 27,728 | SEC↗ |
| Wilder Thomas | Director | A Award | 2016-06-02 | 2016-06-03 | 7,657 | — | $0 | 28,238 | SEC↗ |
| WALLER GREGORY D | Director | A Award | 2016-06-02 | 2016-06-03 | 7,657 | — | $0 | 35,528 | SEC↗ |
| Lemaitre Dan | Director | A Award | 2016-06-02 | 2016-06-03 | 11,485 | — | $0 | 46,167 | SEC↗ |
| Norwalk Leslie V | Director | A Award | 2016-06-02 | 2016-06-03 | 7,657 | — | $0 | 20,669 | SEC↗ |
| Zenty III Thomas F | Director | A Award | 2016-06-02 | 2016-06-03 | 7,657 | — | $0 | 35,574 | SEC↗ |
| NEELS GUIDO J | Director | A Award | 2016-06-02 | 2016-06-06 | 7,657 | — | $0 | 28,380 | SEC↗ |
| DePalma Amanda L. | VP, Global Marketing | S Sale | 2016-06-01 | 2016-06-02 | 689 | $12.55 | $8.6K | 43,772 | SEC↗ |
| DePalma Amanda L. | VP, Global Marketing | A Award | 2016-06-01 | 2016-06-02 | 5,425 | — | $0 | 44,461 | SEC↗ |
| Jennings David M. | VP-Human Resources | S Sale | 2016-06-01 | 2016-06-02 | 957 | $12.55 | $12.0K | 50,281 | SEC↗ |
| Jennings David M. | VP-Human Resources | A Award | 2016-06-01 | 2016-06-02 | 7,535 | — | $0 | 51,238 | SEC↗ |
| McDermott John D | Chief Executive Officer | S Sale | 2016-06-01 | 2016-06-02 | 6,116 | $12.55 | $76.8K | 657,508 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2016-06-01 | 2016-06-02 | 48,222 | — | $0 | 663,624 | SEC↗ |
| Lima Jose A. | VP-Quality | A Award | 2016-06-01 | 2016-06-02 | 7,535 | — | $0 | 38,841 | SEC↗ |
| Lima Jose A. | VP-Quality | S Sale | 2016-06-01 | 2016-06-02 | 957 | $12.55 | $12.0K | 37,884 | SEC↗ |
| DeJohn Joseph A. | General Manager, Asia & Pac | S Sale | 2016-06-01 | 2016-06-02 | 957 | $12.55 | $12.0K | 157,847 | SEC↗ |
| DeJohn Joseph A. | General Manager, Asia & Pac | A Award | 2016-06-01 | 2016-06-02 | 7,535 | — | $0 | 158,804 | SEC↗ |
| Mitchell Robert D | President | S Sale | 2016-06-01 | 2016-06-02 | 2,294 | $12.55 | $28.8K | 315,939 | SEC↗ |
| Mitchell Robert D | President | A Award | 2016-06-01 | 2016-06-02 | 18,083 | — | $0 | 318,233 | SEC↗ |
| Machek James Edward | VP-Research & Development | A Award | 2016-06-01 | 2016-06-02 | 7,535 | — | $0 | 39,243 | SEC↗ |
| Machek James Edward | VP-Research & Development | S Sale | 2016-06-01 | 2016-06-02 | 957 | $12.55 | $12.0K | 38,286 | SEC↗ |
| Machek James Edward | VP-Research & Development | S Sale | 2016-05-26 | 2016-05-27 | 6,500 | $12.76 | $82.9K | 39,243 | SEC↗ |
| DeJohn Joseph A. | General Manager, Asia & Pac | F Tax w/h | 2016-05-25 | 2016-05-27 | 1,046 | $11.87 | $12.4K | 158,804 | SEC↗ |
| DeJohn Joseph A. | General Manager, Asia & Pac | A Award | 2016-05-25 | 2016-05-27 | 2,781 | — | $0 | 159,850 | SEC↗ |
| Lima Jose A. | VP-Quality | A Award | 2016-05-23 | 2016-05-25 | 885 | — | $0 | 39,174 | SEC↗ |
| Lima Jose A. | VP-Quality | F Tax w/h | 2016-05-23 | 2016-05-25 | 333 | — | $0 | 38,841 | SEC↗ |
| McDermott John D | Chief Executive Officer | F Tax w/h | 2016-05-23 | 2016-05-25 | 6,652 | — | $0 | 663,624 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2016-05-23 | 2016-05-25 | 17,699 | — | $0 | 670,276 | SEC↗ |
| Machek James Edward | VP-Research & Development | A Award | 2016-05-23 | 2016-05-25 | 2,023 | — | $0 | 46,504 | SEC↗ |
| Machek James Edward | VP-Research & Development | F Tax w/h | 2016-05-23 | 2016-05-25 | 761 | — | $0 | 45,743 | SEC↗ |
| Chavez Christopher G. | Director | J Other | 2016-04-25 | 2016-04-25 | 328,586 | — | $0 | 355,540 | SEC↗ |
| Chavez Christopher G. | Director | J Other | 2016-02-29 | 2016-04-25 | 65,640 | — | $0 | 65,640 | SEC↗ |
| Chavez Christopher G. | Director | J Other | 2016-02-29 | 2016-04-25 | 65,640 | — | $0 | 65,640 | SEC↗ |
| Chavez Christopher G. | Director | J Other | 2016-02-29 | 2016-03-02 | 285,280 | — | $0 | 312,234 | SEC↗ |
| Chavez Christopher G. | Director | J Other | 2016-02-29 | 2016-03-02 | 65,640 | — | $0 | 65,640 | SEC↗ |
| Chavez Christopher G. | Director | J Other | 2016-02-29 | 2016-03-02 | 65,640 | — | $0 | 65,640 | SEC↗ |
| Chobotov Michael V. | Chief Technology Officer | J Other | 2016-02-29 | 2016-03-02 | 116,948 | — | $0 | 203,269 | SEC↗ |
| O'Quinn Shari L | VP, Clinical & Regulatory | J Other | 2016-02-29 | 2016-03-02 | 18,681 | — | $0 | 58,522 | SEC↗ |
| O'Quinn Shari L | VP, Clinical & Regulatory | S Sale | 2016-02-29 | 2016-03-02 | 4,000 | — | $0 | 54,522 | SEC↗ |
| Chobotov Michael V. | Chief Technology Officer | A Award deriv | 2016-02-04 | 2016-02-05 | 188,406 | $7.53 | $1.42M | 188,406 | SEC↗ |
| O'Quinn Shari L | VP, Clinical & Regulatory | A Award deriv | 2016-02-04 | 2016-02-05 | 86,957 | $7.53 | $654.8K | 86,957 | SEC↗ |
| Machek James Edward | VP-Research & Development | A Award deriv | 2016-02-04 | 2016-02-17 | 43,478 | $7.53 | $327.4K | 43,478 | SEC↗ |
| Ferracci Cecile | General Manager, Europe | A Award deriv | 2016-02-04 | 2016-02-17 | 40,580 | $7.53 | $305.6K | 40,580 | SEC↗ |
| Jennings David M. | VP-Human Resources | A Award deriv | 2016-02-04 | 2016-02-17 | 42,029 | $7.53 | $316.5K | 42,029 | SEC↗ |
| DeJohn Joseph A. | VP- Global Sales | A Award deriv | 2016-02-04 | 2016-02-17 | 40,580 | $7.53 | $305.6K | 40,580 | SEC↗ |
| DePalma Amanda L. | VP, Global Marketing | A Award deriv | 2016-02-04 | 2016-02-17 | 46,377 | $7.53 | $349.2K | 46,377 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award deriv | 2016-02-04 | 2016-02-17 | 362,319 | $7.53 | $2.73M | 362,319 | SEC↗ |
| Lima Jose A. | VP-Quality | A Award deriv | 2016-02-04 | 2016-02-17 | 37,681 | $7.53 | $283.7K | 37,681 | SEC↗ |
| Mitchell Robert D | President | A Award deriv | 2016-02-04 | 2016-02-17 | 115,942 | $7.53 | $873.0K | 115,942 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award deriv | 2016-02-04 | 2016-02-17 | 115,942 | $7.53 | $873.0K | 115,942 | SEC↗ |
| Chobotov Michael V. | Chief Technology Officer | A Award | 2016-02-04 | 2016-02-05 | 86,321 | — | $0 | 86,321 | SEC↗ |
| O'Quinn Shari L | VP, Clinical & Regulatory | A Award | 2016-02-04 | 2016-02-05 | 39,841 | — | $0 | 39,841 | SEC↗ |
| Machek James Edward | VP-Research & Development | A Award | 2016-02-04 | 2016-02-17 | 13,280 | — | $0 | 46,504 | SEC↗ |
| Ferracci Cecile | General Manager, Europe | A Award | 2016-02-04 | 2016-02-17 | 11,952 | — | $0 | 40,706 | SEC↗ |
| Jennings David M. | VP-Human Resources | A Award | 2016-02-04 | 2016-02-17 | 12,616 | — | $0 | 49,681 | SEC↗ |
| DeJohn Joseph A. | VP- Global Sales | A Award | 2016-02-04 | 2016-02-17 | 11,952 | — | $0 | 158,627 | SEC↗ |
| DePalma Amanda L. | VP, Global Marketing | A Award | 2016-02-04 | 2016-02-17 | 14,608 | — | $0 | 43,423 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2016-02-04 | 2016-02-17 | 106,242 | — | $0 | 667,506 | SEC↗ |
| Lima Jose A. | VP-Quality | A Award | 2016-02-04 | 2016-02-17 | 11,952 | — | $0 | 38,240 | SEC↗ |
| Mitchell Robert D | President | A Award | 2016-02-04 | 2016-02-17 | 33,201 | — | $0 | 315,462 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2016-02-04 | 2016-02-17 | 33,201 | — | $0 | 88,511 | SEC↗ |
| Chobotov Michael V. | Chief Technology Officer | A Award | 2016-02-03 | 2016-09-26 | 116,948 | $7.42 | $867.8K | 203,269 | SEC↗ |
| Chavez Christopher G. | Director | A Award | 2016-02-03 | 2016-02-05 | 26,954 | — | $0 | 26,954 | SEC↗ |
| Love Charles Steele | VP-Clinical Affairs | S Sale | 2016-01-26 | 2016-01-28 | 4,280 | $7.72 | $33.0K | 45,037 | SEC↗ |
| Machek James Edward | VP-Research & Development | F Tax w/h | 2016-01-04 | 2016-01-04 | 676 | $10.01 | $6.8K | 33,224 | SEC↗ |
| Machek James Edward | VP-Research & Development | A Award | 2016-01-04 | 2016-01-04 | 1,797 | — | $0 | 33,900 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award | 2015-11-13 | 2015-11-17 | 22,779 | — | $0 | 569,825 | SEC↗ |
| McDermott John D | Chief Executive Officer | F Tax w/h | 2015-11-13 | 2015-11-17 | 8,561 | $9.04 | $77.4K | 561,264 | SEC↗ |
| DeJohn Joseph A. | VP- Global Sales | A Award | 2015-11-13 | 2015-11-17 | 3,797 | — | $0 | 148,102 | SEC↗ |
| DeJohn Joseph A. | VP- Global Sales | F Tax w/h | 2015-11-13 | 2015-11-17 | 1,427 | $9.04 | $12.9K | 146,675 | SEC↗ |
| Abraham Todd | VP of Operations | A Award | 2015-11-13 | 2015-11-17 | 3,417 | — | $0 | 88,106 | SEC↗ |
| Abraham Todd | VP of Operations | F Tax w/h | 2015-11-13 | 2015-11-17 | 1,285 | $9.04 | $11.6K | 86,821 | SEC↗ |
| Mitchell Robert D | President | A Award | 2015-11-13 | 2015-11-17 | 5,695 | — | $0 | 285,233 | SEC↗ |
| Mitchell Robert D | President | F Tax w/h | 2015-11-13 | 2015-11-17 | 2,972 | $9.04 | $26.9K | 282,261 | SEC↗ |
| Machek James Edward | VP-Research & Development | A Award | 2015-11-13 | 2015-11-17 | 3,037 | — | $0 | 35,042 | SEC↗ |
| Machek James Edward | VP-Research & Development | F Tax w/h | 2015-11-13 | 2015-11-17 | 1,142 | $9.04 | $10.3K | 33,900 | SEC↗ |
| Lima Jose A. | VP-Quality | F Tax w/h | 2015-11-13 | 2015-11-17 | 500 | $9.04 | $4.5K | 26,288 | SEC↗ |
| Lima Jose A. | VP-Quality | A Award | 2015-11-13 | 2015-11-17 | 1,329 | — | $0 | 26,788 | SEC↗ |
| Abraham Todd | VP of Operations | P Buy | 2015-11-03 | 2015-11-03 | 2,500 | $8.85 | $22.1K | 88,106 | SEC↗ |
| NEELS GUIDO J | Director | P Buy | 2015-11-03 | 2015-11-03 | 11,000 | $9.32 | $102.5K | 38,055 | SEC↗ |
| McDermott John D | Chief Executive Officer | P Buy | 2015-11-02 | 2015-11-03 | 20,000 | $8.90 | $178.0K | 569,825 | SEC↗ |
| Thunen Shelley B | Other | J Other | 2015-10-19 | 2015-10-21 | 36,852 | — | $0 | 17,143 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award deriv | 2015-10-15 | 2015-10-16 | 137,024 | $13.56 | $1.86M | 137,024 | SEC↗ |
| Mahboob Vaseem | Chief Financial Officer | A Award | 2015-10-15 | 2015-10-16 | 55,310 | — | $0 | 55,310 | SEC↗ |
| Lima Jose A. | VP-Quality | S Sale | 2015-09-03 | 2015-09-04 | 1,923 | $12.60 | $24.2K | 24,825 | SEC↗ |
| Machek James Edward | VP-Research & Development | S Sale | 2015-08-07 | 2015-08-10 | 1,250 | $12.63 | $15.8K | 35,042 | SEC↗ |
| Machek James Edward | VP-Research & Development | A Award deriv | 2015-05-28 | 2015-06-01 | 18,854 | — | $0 | 18,854 | SEC↗ |
| Lima Jose A. | VP-Quality | A Award deriv | 2015-05-28 | 2015-06-01 | 18,854 | — | $0 | 18,854 | SEC↗ |
| Fauls Janet Mary | VP Regulatory Affairs | A Award deriv | 2015-05-28 | 2015-06-01 | 18,854 | — | $0 | 18,854 | SEC↗ |
| DePalma Amanda L. | VP, Global Marketing | A Award deriv | 2015-05-28 | 2015-06-01 | 13,575 | — | $0 | 13,575 | SEC↗ |
| Abraham Todd | VP of Operations | A Award deriv | 2015-05-28 | 2015-06-01 | 22,624 | — | $0 | 22,624 | SEC↗ |
| DeJohn Joseph A. | VP- Global Sales | A Award deriv | 2015-05-28 | 2015-06-01 | 18,854 | — | $0 | 18,854 | SEC↗ |
| McDermott John D | Chief Executive Officer | A Award deriv | 2015-05-28 | 2015-06-01 | 120,644 | — | $0 | 120,644 | SEC↗ |
| Mitchell Robert D | President | A Award deriv | 2015-05-28 | 2015-06-01 | 45,249 | — | $0 | 45,249 | SEC↗ |
| Love Charles Steele | VP-Clinical Affairs | A Award deriv | 2015-05-28 | 2015-06-01 | 18,854 | — | $0 | 18,854 | SEC↗ |
| Jennings David M. | VP-Human Resources | A Award deriv | 2015-05-28 | 2015-06-01 | 18,854 | — | $0 | 18,854 | SEC↗ |